Creating electronic versions of documents and processes underlying clinical trials is becoming the...
- Exploring efficiencies from eTMF with Cancer Research UK
- Diaceutics invests in patient data to improve outcomes
- British universities must improve clinical trial reporting, says House of Commons
- Expert Insights: Moderna Therapeutics Barrels Ahead Towards Historic IPO
- Industry Viewpoints: Leveraging eSource in Data Management
Exploring efficiencies from eTMF with Cancer Research UK
Creating electronic versions of documents and processes underlying clinical trials is becoming the norm. Cancer Research UK’s Stephen Nabarro walk us through its implementation of Veeva Vault eTMF two years ago, focusing on the challenges and efficiency benefit it has brought to the charity in its clinical trials work.
August’s top news stories
Biopharmaceutical firm Retrophin reported that the Phase III clinical trial of fosmetpantotenate failed to meet endpoints in pantothenate kinase-associated neurodegeneration (PKAN) patients; and MyoKardia has commenced dosing of patients in a Phase I trial of small molecule MYK-224 for the treatment of hypertrophic cardiomyopathy (HCM). Clinicaltrialsarena.com wraps up the key headlines from August 2019.
Idorsia Pharmaceuticals selects Arkivum to preserve clinical data
Switzerland-based Idorsia Pharmaceuticals has selected Arkivum to protect and digitally store its clinical trial and research data.
Scientist.com and Austrade to expand digital research marketplace in Australia
Scientist.com, the B2B marketplace for outsourced research and development (R&D) services, has partnered with Australian Trade and Investment Commission (Austrade).
Diaceutics invests in patient data to improve outcomes
Diaceutics has announced an investment of £1m ($1.1m) to expand and enhance its data lake by acquiring another 16 million patient records a year.
HMA publishes recommendations on complex clinical trials of personalised medicine
A subgroup of the EU’s Heads of Medicines Agencies (HMA) has published a set of common recommendations with regard to conducting complex clinical trials of personalised medicine.
British universities must improve clinical trial reporting, says House of Commons
The House of Commons Science and Technology Select Committee has announced that UK universities could be brought in for questioning if they fail to improve the transparency of their clinical trial procedure.
Report finds 800 UK university trials could become research waste
A new report by TranspariMED and Universities Allies for Essential Medicines UK has found that as many as 800 clinical trials by UK universities could become research waste as they violate reporting rules.